https://pittplusme.org/study/covidvaccine
"Next Generation" COVID Study
STUDY BASICS
We are looking for participants for a COVID vaccine research study. This study is looking into “Next Generation” vaccines to combat COVID. These investigational study vaccines aim to have greater amount of protection to variants, increased durability, and ability to block transmission and viral infection. Compensation is provided.
STUDY PURPOSE
The purpose of this study is to test the safety and immune response to an experimental COVID-19 vaccine given as a single booster dose.
COULD THIS STUDY BE RIGHT FOR YOU?
Adults aged 18 through 64 years who are in a stable state of health may enroll.
WHAT PARTICIPANTS CAN EXPECT
- Screening visit to determine eligibility
- Multiple visits involving blood draws, nasal, and oral swabs
- 1 visit with study vaccine administration
IRB: SSU00303410
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health - DMID 25-1106, A Phase 1, Open-Label, Safety and Immunogenicity Trial of Boost-2867, an IgG-FcRBD Fusion Protein Next Generation SARS-CoV-2 Booster Vaccine, Via Intranasal and Intramuscular Routes in Previously Vaccinated Adults (Pro00090304)
MEET THE RESEARCHER
Judy Martin
Judy Martin, MD is a Professor of Pediatrics in the Division of General Academic Pediatrics at the University of Pittsburgh School of Medicine. A graduate of the University of Pennsylvania and Mount Sinai Icahn School of Medicine, Dr. Martin’s research interests include vaccine research, Group A streptococcal infections, and rheumatic fever.